Educational Notice
Peptidings provides information for educational and research purposes only. The peptides discussed on this page are subjects of ongoing scientific research. None of the information presented here constitutes medical advice or a recommendation for use. Consult a qualified healthcare provider before making any decisions about peptide use.
Browse by Condition
Tendon & Ligament Healing
Tendon and ligament healing is the most-cited application for several compounds in self-experimentation communities, particularly BPC-157. The preclinical data here is genuinely interesting and more extensive than in most other areas where peptides are discussed. The human data, however, is limited—and the translation from rodent tendon models to human clinical outcomes is not assured. The Named Protocols guide covers the Wolverine Protocol, which is the most common community-documented approach to stacking compounds for connective tissue repair, and is worth reading alongside the individual compound articles.
Approved Drug
Clinical Trials
Pilot / Human Data
Preclinical Only
It’s Complicated
Compounds with Research Relevant to Tendon and Ligament Healing
Each compound links to its full pillar article. The most useful sections for evaluating a specific application are the Claims vs. Evidence table and the Safety, Risks, and Limitations section. Evidence tiers reflect the strongest available data for a compound overall—not necessarily for this specific application.
WADA
BPC-157: What the Research Says about This Pentadecapeptide
Gastric pentadecapeptide studied for tissue repair, tendon healing, and gut protection. Pilot human data only; WADA prohibited.
Read the research →
WADA
TB-500: What the Research Says about Thymosin Beta-4’s Synthetic Fragment
Synthetic Thymosin Beta-4 fragment studied for tissue repair and cell migration. Preclinical evidence only; WADA prohibited.
Read the research →
WADA
Thymosin Beta-4: What the Research Shows
Endogenous 43-amino acid actin-sequestering peptide studied for wound healing, cardiac repair (RGN-352 Phase II), and corneal regeneration (RGN-259). TB-500 is its synthetic fragment — distinct compounds.
Read the research →
Guides Relevant to This Condition
Named Protocols Explainer
Wolverine, GLOW, and KLOW protocols—what they stack, what they don’t justify
How to Reconstitute Lyophilized Peptides
Bacteriostatic water, reconstitution ratios, vial handling
Peptide Injection Technique Guide
Subcutaneous and intramuscular injection, site rotation, safety
Research Cluster
These compounds are covered in depth in the Injury Recovery and Tissue Repair cluster hub.
Disclaimer: This page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. The compounds discussed have not been evaluated by the FDA for all applications described. Consult a qualified healthcare provider before making any decisions about your health.
